An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer (NK) cells in an animal model, a study led by UT Southwestern Medical ...
Feb 17, 2025
0
61
Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors—a type of immunotherapy—using only routine blood ...
Jan 7, 2025
0
53
A team of researchers at IRB Barcelona has identified five independent factors that predict cancer patients' response to checkpoint inhibitors (CPIs). The study, which has been published in Nature Genetics, validates these ...
Sep 12, 2024
0
28
A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrates a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Sep 7, 2024
0
0
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern ...
May 23, 2024
0
37
Over the last decade, immunotherapies, particularly immune checkpoint inhibitors (ICIs), have emerged as promising treatments for various cancer types. However, a notable challenge in immuno-oncology trials is the frequent ...
Mar 20, 2024
0
0
The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression two years after discontinuing treatment, ...
Dec 18, 2023
0
2
In a discovery that could improve the survival of bladder cancer patients, Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.
Apr 27, 2023
0
4
Women with triple-negative breast cancer who received multiple antibiotic prescriptions within three years after their cancer diagnosis were more likely to experience disease recurrence and to die from their cancer than those ...
Apr 21, 2023
0
83
A new artificial intelligence model designed by researchers at Harvard Medical School and National Cheng Kung University in Taiwan could bring much-needed clarity to doctors delivering prognoses and deciding on treatments ...
Apr 13, 2023
0
31
